Open a Public Inquiry into Covid-19 Vaccine Safety

There has been a significant increase in heart attacks and related health issues since the rollout of the Covid-19 vaccines began in 2021. This needs immediate and full scientific investigation to establish if there is any possible link with the Covid-19 vaccination rollout.

64,821 Signatures

Status
Open
Opened
Monday 6th December 2021
Last 24 hours signatures
310
Signature Deadline
Monday 6th June 2022
Estimated Final Signatures: 101,669

This content was generated for your convenience by Parallel Parliament and does not form part of the official record.
Recent Documents related to Open a Public Inquiry into Covid-19 Vaccine Safety

1. Open a Public Inquiry into Covid-19 Vaccine Safety
29/11/2021 - Petitions

Found: been a significant increase in heart attacks and related health issues since the rollout of the Covid-19

2. Investigation into preparations for potential COVID-19 vaccines
16/12/2020 - National Audit Office

Found: Investigation into preparations for potential COVID-19 vaccines - National Audit Office (NAO)

3. UK COVID-19 vaccines delivery plan
11/01/2021 - Department of Health and Social Care
- View source

Found: UK COVID -19 vaccines delivery plan Contents 1. Ministerial foreword ....................

4. Summary - Investigation into preparations for potential COVID-19 vaccines
16/12/2020 - National Audit Office

Found: England Investigation into preparations for potential COVID-19 vaccines HC 1071 SESSION 2019˚2021 16 DECEMBER

5. Report - Investigation into preparations for potential COVID-19 vaccines
16/12/2020 - National Audit Office

Found: England Investigation into preparations for potential COVID-19 vaccines HC 1071 SESSION 2019˚2021 16 DECEMBER

Latest Documents
Recent Speeches related to Open a Public Inquiry into Covid-19 Vaccine Safety

1. Health Protection (Coronavirus, Restrictions) (Self-Isolation and Linked Households) (England) Regulations 2020
07/01/2021 - Lords Chamber

1: than a million people in Britain infected with Covid. A third are asymptomatic, and most are highly infectious - Speech Link

2. COVID-19 Pandemic in Latin America
20/10/2021 - Lords Chamber

1: disproportionate 20% of Covid infections and a third of global deaths. The response to Covid has varied enormously - Speech Link

3. Covid-19 Update
07/01/2021 - Lords Chamber

1: measures we are taking to defeat this new variant of Covid-19, protecting our NHS while it carries out the vaccinations - Speech Link
2: the plan drawn up by the Joint Committee on Vaccination and Immunisation, which is aimed at saving the - Speech Link
3: that target, there are already almost 1,000 vaccination centres across the country, including 595 GP-led - Speech Link

4. Covid-19 Update
15/06/2021 - Lords Chamber

1: involved in a race between the vaccine and the virus. Our vaccination programme has been delivered at - Speech Link
2: meaning that right now we have one of the most open economies and societies in Europe. We have been - Speech Link
3: purpose of vaccination is to break the link between cases and hospitalisations and deaths. That link is clearly - Speech Link

5. Health Protection (Coronavirus, Restrictions) (All Tiers) (England) (Amendment) (No. 2) Regulations 2020
30/12/2020 - Lords Chamber

1: which has concluded that the vaccine has met its strict standards of safety, quality and effectiveness - Speech Link

Latest Speeches
Recent Questions related to Open a Public Inquiry into Covid-19 Vaccine Safety
Latest Questions

You may be interested in these active petitions

1. Don't offer covid-19 vaccine to 5-11 year olds until phase 3 trials complete - 6,488 signatures
2. Prohibit employers from requiring staff to be vaccinated against Covid-19 - 214,391 signatures
3. Do not make vaccination against Covid-19 mandatory - 25,764 signatures
4. Do not make Covid-19 vaccination a requirement to physically attend university - 12,061 signatures
5. Make the day of Diwali a public holiday - 16,617 signatures

It is the duty of the Government to ensure that the prescribed medical interventions of its response to Coronavirus are safe. We believe that the recent and increasing volume of data relating to cardiovascular problems since the Covid-19 vaccine rollout began is of enough concern to warrant a full Public Inquiry.


Petition Signatures over time

Government Response

Wednesday 5th January 2022

The Government commissioned a public inquiry into the pandemic and has no plans for a vaccine safety inquiry. Our surveillance strategy for COVID-19 vaccines provides continuous safety monitoring.


The Government has commissioned a public inquiry into the COVID-19 pandemic and has no plans for a separate inquiry on vaccine safety. The safety of COVID-19 vaccines is monitored by the Medicines Healthcare and Regulatory products Agency (MHRA).

The MHRA has authorised COVID-19 vaccine supply following a rigorous review of their safety, quality and efficacy. The clinical trials of the vaccines have shown them to be effective and acceptably safe; however, as part of its statutory functions, the MHRA continually monitors the use of the vaccines to ensure their benefits continue to outweigh any risks. This is a requirement for all authorised medicines and vaccines in the UK. This monitoring strategy is continuous, proactive and based on a wide range of information sources, with a dedicated team of scientists reviewing information daily to look for safety issues or unexpected events.

The MHRA operates the Yellow Card scheme to collect and monitor information on suspected safety concerns or incidents involving vaccines, medicines, medical devices, and e-cigarettes. The scheme relies on voluntary reporting of suspected adverse incidents by healthcare professionals and members of the public. The scheme is designed to provide an early warning that the safety of a product may require further investigation.

Up to and including 15 December 2021, the MHRA received and analysed: 145,446 Adverse Event reports (ADRs) from people who have received the Pfizer/BioNTech vaccine; 240,065 UK reports of suspected ADRs to the AstraZeneca vaccine; 24,721 UK reports of suspected ADRs to the Moderna vaccine. For context, up to same date, approximately 46.4 million Pfizer/BioNTech Vaccines, 50 million AstraZeneca vaccines and 2.8 million Moderna doses had been administered as first and second doses.

The overwhelming majority of these reports relate to injection-site reactions (sore arm for example) and generalised symptoms such as ‘flu-like’ illness, headache, chills, fatigue (tiredness), nausea (feeling sick), fever, dizziness, weakness, aching muscles, and rapid heartbeat. Generally, these happen shortly after the vaccination and are not associated with more serious or lasting illness. These types of reactions reflect the normal immune response triggered by the body to the vaccines. They are typically seen with most types of vaccine and tend to resolve within a day or two.

The continuous review of available evidence from UK Yellow Card reports of suspected side-effects to the vaccines and other healthcare data does not suggest that the COVID-19 vaccines increase the risk of cardiovascular events such as heart attacks. The benefits of the vaccines in preventing COVID-19 and serious complications associated with COVID-19 continue to far outweigh the risks in the majority of patients.

However, the MHRA has identified the rare occurrence of myocarditis and pericarditis (both inflammatory conditions of the heart) following vaccination against COVID-19. There has been a consistent pattern of higher reporting of these rare, suspected events with the Pfizer/BioNTech vaccine Moderna vaccine, and of these occurring more frequently in males. Following analysis combined with advice from the Commission on Human Medicines, the product information for the Moderna and Pfizer/BioNTech Vaccines was updated to inform of these reports and advise healthcare professionals and patients to be aware of important symptoms for myocarditis and pericarditis. These reports are very rare, with the overall reporting rate across all age groups as follows:

Pfizer/BioNTech Vaccine: For suspected myocarditis (including viral myocarditis) the reporting rate is 12 reports per million doses, and for suspected pericarditis (including viral pericarditis and infective pericarditis) the overall reporting rate is 8 reports per million doses.

Moderna Vaccine: The overall reporting rate for suspected myocarditis is 42 per million doses and for suspected pericarditis is 24 per million doses.

AstraZeneca Vaccine: The overall reporting rate for suspected myocarditis (including viral myocarditis and infectious myocarditis) is 4 per million doses and for suspected pericarditis (including viral pericarditis) is 4 per million doses.

These events reported are typically mild with individuals usually recovering within a short time with standard treatment and rest.

The MHRA will continue to closely monitor reports of suspected myocarditis and pericarditis with all of the currently authorised COVID-19 vaccines, as it continues to do with any concerns that the Yellow Card Scheme might raise. Vaccines are the best way to protect people from COVID-19 and have already saved tens of thousands of lives. More information on the Yellow Card Scheme can be found at the following link:
www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting

Department of Health and Social Care


Constituency Data

Reticulating Splines